Globus Medical (GMED) Misses Q1 EPS by 7c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher on revived AI momentum
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Globus Medical (GMED) PT Lowered to $78 at Oppenheimer
May 9, 2025 10:21 AM EDTOppenheimer analyst Steven Lichtman lowered the price target on Globus Medical (NYSE: GMED) to $78.00 (from $90.00) while maintaining a Perform rating.
The analyst commented, "Globus Medical's 1Q25 sales of $598.1 (-0.8% constant currency) missed our/Street's ~$630.1/$626M estimates. Musculoskeletal was softer on several factors including timing... More



